Excepgen
Excepgen is a healthcare company based in San Francisco, specializing in innovative gene therapies and vaccines, focusing on rare diseases, preventative and therapeutic vaccines, and gene therapy.
Company History
Excepgen, initially known as Excepgen INC, operates from its headquarters at 780 Bryant St., San Francisco, CA 94107. The company, a participant of the Y Combinator batch W19, is a healthcare entity specializing in gene therapies and vaccines. It employs a small but dedicated team of three professionals and is actively involved in therapeutic developments aimed at addressing rare diseases and enhancing cellular responses to nucleic acids.
Industry Focus
Excepgen operates within the healthcare industry, specifically in the therapeutics sub-sector. The company focuses on pioneering gene therapies and vaccines powered by innovative DNA and mRNA technologies. By emphasizing preventative and therapeutic vaccines along with treatments for rare diseases, Excepgen positions itself as a vital player in modern medical advancements.
Core Initiatives
Excepgen's core initiatives revolve around developing preventative and therapeutic vaccines, addressing rare diseases, and advancing gene therapy. These initiatives are driven by a focus on improving the cellular response to nucleic acids, aiming to dampen undesirable pathways. The company aims to push the boundaries of medical research and treatment in these areas.
Work Environment and Culture
Excepgen promotes a work environment that fosters curiosity and creative discussion. It seeks individuals passionate about improving the drug discovery and development processes. Ideal candidates are those capable of bridging gaps between biochemistry, cell biology, and therapeutic design, contributing to the company's innovative approach in the therapeutics field.
Global Presence
Excepgen has a regional focus on the United States and the broader America/Canada region. While headquartered in San Francisco, CA, the company's influence and operations extend throughout these areas, reflecting its commitment to addressing healthcare challenges on a larger geographical scale.